Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Share-based Compensation (2016 - 2025)

Collegium Pharmaceutical has reported Share-based Compensation over the past 10 years, most recently at $9.8 million for Q4 2025.

  • Quarterly results put Share-based Compensation at $9.8 million for Q4 2025, up 28.4% from a year ago — trailing twelve months through Dec 2025 was $41.9 million (up 29.34% YoY), and the annual figure for FY2025 was $41.9 million, up 29.34%.
  • Share-based Compensation for Q4 2025 was $9.8 million at Collegium Pharmaceutical, down from $9.8 million in the prior quarter.
  • Over the last five years, Share-based Compensation for COLL hit a ceiling of $11.5 million in Q1 2025 and a floor of $4.9 million in Q4 2021.
  • Median Share-based Compensation over the past 5 years was $7.0 million (2023), compared with a mean of $7.4 million.
  • Biggest five-year swings in Share-based Compensation: skyrocketed 442.16% in 2021 and later decreased 12.65% in 2022.
  • Collegium Pharmaceutical's Share-based Compensation stood at $4.9 million in 2021, then rose by 15.43% to $5.7 million in 2022, then rose by 23.49% to $7.0 million in 2023, then grew by 8.48% to $7.6 million in 2024, then rose by 28.4% to $9.8 million in 2025.
  • The last three reported values for Share-based Compensation were $9.8 million (Q4 2025), $9.8 million (Q3 2025), and $10.8 million (Q2 2025) per Business Quant data.